Biologics Market Revenue 2024 to 2034
Biologics Market Revenue 2024 to 2034
The biologics market size is projected to reach USD 938.04 billion by 2034, growing from USD 485.19 billion in 2025, at a CAGR of 7.6% during the forecast period from 2025 to 2034.
Report ID: 10056
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 450.92 Bn
Forecast Year,
USD USD 938.04 Bn
CAGR, 2025 -
7.6%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Biologics Market Size Analysis
Biologics Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood and Blood Products | 126.26 | 136.10 | 146.70 | 158.13 | 170.45 | 183.73 | 198.04 | 213.47 | 230.10 | 248.02 | 267.34 |
| Cellular and Gene Therapy Products | 94.69 | 102.18 | 110.26 | 118.98 | 128.38 | 138.53 | 149.48 | 161.29 | 174.03 | 187.78 | 202.62 |
| Tissue and Tissue Products | 67.64 | 72.63 | 78.00 | 83.76 | 89.94 | 96.58 | 103.71 | 111.37 | 119.59 | 128.41 | 137.89 |
| Vaccines | 112.73 | 121.49 | 130.93 | 141.11 | 152.07 | 163.89 | 176.63 | 190.35 | 205.15 | 221.09 | 238.26 |
| Others Types | 49.60 | 52.79 | 56.17 | 59.77 | 63.59 | 67.64 | 71.94 | 76.50 | 81.35 | 86.48 | 91.93 |
Biologics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 189.39 | 203.97 | 219.68 | 236.60 | 254.83 | 274.46 | 295.60 | 318.36 | 342.88 | 369.29 | 397.73 |
| Immunology | 121.75 | 131.15 | 141.27 | 152.18 | 163.92 | 176.58 | 190.21 | 204.89 | 220.70 | 237.74 | 256.08 |
| Infectiuos Disease | 81.17 | 87.43 | 94.18 | 101.45 | 109.28 | 117.72 | 126.80 | 136.59 | 147.13 | 158.49 | 170.72 |
| Other Indications | 58.62 | 62.64 | 66.93 | 71.51 | 76.40 | 81.62 | 87.20 | 93.14 | 99.49 | 106.27 | 113.50 |
Biologics Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | 157.82 | 169.91 | 182.93 | 196.95 | 212.03 | 228.28 | 245.77 | 264.60 | 284.87 | 306.70 | 330.19 |
| Treatment | 293.10 | 315.28 | 339.13 | 364.79 | 392.40 | 422.09 | 454.03 | 488.38 | 525.34 | 565.09 | 607.85 |
Biologics Market Size By Manufacturing Facility 2024 to 2034 (USD )
| Manufacturing Facility | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Outsourced | 216.44 | 232.75 | 250.28 | 269.13 | 289.40 | 311.20 | 334.64 | 359.85 | 386.96 | 416.11 | 447.45 |
| In-house | 234.48 | 252.44 | 271.78 | 292.61 | 315.03 | 339.17 | 365.16 | 393.13 | 423.25 | 455.68 | 490.59 |
Biologics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 175.86 | 189.13 | 203.39 | 218.74 | 235.24 | 252.99 | 272.08 | 292.61 | 314.69 | 338.43 | 363.96 |
| Europe | 121.75 | 130.95 | 140.85 | 151.50 | 162.95 | 175.27 | 188.53 | 202.78 | 218.11 | 234.60 | 252.33 |
| Asia-Pacific | 99.20 | 106.89 | 115.17 | 124.09 | 133.70 | 144.06 | 155.22 | 167.24 | 180.19 | 194.15 | 209.18 |
| Latin America | 31.56 | 34.01 | 36.65 | 39.49 | 42.55 | 45.85 | 49.41 | 53.24 | 57.36 | 61.81 | 66.60 |
| Middle East & Africa | 22.55 | 24.21 | 26.00 | 27.92 | 29.98 | 32.19 | 34.57 | 37.12 | 39.86 | 42.80 | 45.96 |
Biologics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
